8:00 AM - 8:45 AM | Fisher Atrium, UCSF Mission Bay Conference Center

Registration will open at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Guests can meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more.

Photo: Architecture in the Fisher Atrium at the UCSF Mission Bay Conference Center.

8:45 AM - 8:55 AM | Robertson Auditorium at UCSF Mission Bay Conference Center

8:55 AM - 9:15 AM | Laird Cagan, Managing Director and Co-Founder, Cagan McAfee Capital Partners, and San Francisco Chair, TIGER 21

Laird Q. Cagan is Managing Director and co-founder of Cagan McAfee Capital Partners, LLC (successor to Cagan Capital, LLC) a private investment firm he founded in 1990. During the ‘90s Mr. Cagan invested in and helped build 15 high tech companies with over $500MM of equity capital invested in those companies. Since 2002, CMCP has founded, funded and taken public over 10 companies in a variety of industries including energy, alternative energy, healthcare, information technologies, payments and cleantech. CMCP portfolio companies have raised over $600MM of equity capital and over $2B of project development capital.

Photo: Laird Cagan, McAfee Capital Partners and TIGER 21

9:15 AM - 9:45 AM | Featuring John Antretter, Managing Director, Investment Banking, Weild & Co., Inc. (named by La Roche as one of the United States’ fastest-growing investment banks)

John Antretter, Managing Director of Investment Banking at Weild & Co., will welcome Cavendish to the San Francisco Forum, bringing to our Members the latest snapshot of the present state of capital markets, and the implications for early and middle-market companies in fundraising mode. Weild & Co., dedicated to supporting entrepreneurs in the earlier growth stages, explores viable fundraising methodologies that are impactful to executives, investors, consumers and the larger marketplace.

9:45 AM - 10:45 AM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work.

Interested in presenting at the upcoming San Francisco Forum? Contact our team for details.

Photo: Angelika Niemz, PhD, President and CEO, Efyian, delivered a presentation at the 2019 San Francisco Forum.

10:45 AM - 11:30 AM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center

Immediately following Innovation Partner impact presentations, guests will enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations, in the exhibition space.

Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team.

11:30 AM - 12:00 PM | Featuring Lili Gil Valletta, Founder and CEO, CulturIntel, Award-Winning Entrepreneur, Business Strategist, Hispanic Market Expert and Media Commentator

Value-based models, shifting demographics, social determinants and technology are all coming together in today’s fast changing market. This session will outline some of these dynamics and share how cultural intelligence is essential for innovation and better outcomes.

Photo: Lili Gil Valletta, Founder and CEO, CulturIntel

12:00 PM - 12:30 PM | Featuring Bruce L. Gewertz, MD, Renown Surgeon; Surgeon-in-Chief, Chair of the Department of Surgery, H and S Nichols Distinguished Chair in Surgery, Vice President for Interventional Services and Vice Dean for Academic Affairs, Cedars-Sinai Health System, Los Angeles, CA

Photo: Bruce L. Gewertz, MD, Cedars-Sinai Health System

12:30 PM - 1:45 PM | Fisher Atrium at UCSF Mission Bay

Cavendish members and speakers from around the San Francisco Bay Area will break bread together, over a casual buffet lunch at UCSF Mission Bay. Cavendish luncheons never feature keynote speakers, leaving attendees uninterrupted to network, meet and dine.

1:45 PM - 2:15 PM | Lennart Mucke, MD, Director and Senior Investigator, Gladstone Institute for Neurological Disease

Dr. Mucke is the Director of the Gladstone Institute of Neurological Disease. He is also the Joseph B. Martin Distinguished Professor of Neuroscience and a Professor of Neurology at the University of California, San Francisco (UCSF). He has joint appointments in UCSF’s Neuroscience, Biomedical Sciences, and Medical Scientist (MD/PhD) Graduate Training Programs.

Dr. Mucke’s research focuses on processes that result in memory loss and other major neurological deficits, with an emphasis on Alzheimer’s disease and related disorders. He has generated informative experimental models of these conditions and used them to identify novel strategies to prevent neurological decline. As the founding Director of the Gladstone Institute of Neurological Disease, he has created a leading program for research and training in disease-focused neuroscience.

2:15 PM - 3:15 PM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work.

Interested in presenting at the upcoming San Francisco Forum? Contact our team for details.

Photo: Greg Everson, MD, CEO, CMO and Managing Member, HepQuant, delivered a presentation at the 2019 San Francisco Forum.

3:15 PM - 4:00 PM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center

Immediately following Innovation Partner impact presentations, guests will enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations, in the exhibition space.

Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team.

4:00 PM - 4:30 PM | Andrew Chung, Founder and Managing Partner, 1955 Capital

Andrew has been a tech investor and entrepreneur for over 20 years. He founded 1955 Capital to invest in transformative companies that can solve the most pressing issues in the developing world. 1955 was the largest venture capital firm debut in Q1 2016 and focuses on sustainability (energy, food, agriculture), education, health, and other emerging technologies.

Prior to launching 1955 Capital, Andrew was a general partner at Khosla Ventures, a venture capital firm with over $5 billion under management and the world’s largest sustainable technology venture portfolio. Andrew joined Khosla in 2011 as one of six partners leading the firm. He managed over $500 million in assets and has served as board director or helped advise more than 20 Khosla portfolio companies.

4:30 PM - 5:00 PM | Panelists include Karl Handelsman, Founder, Codon Capital and Investment Director, Roche Venture Fund; Trish Costello, Founder and CEO, Portfolia; and Jan Pensaert, Founder and Managing Partner, Valiance Asset Management (London); and Michael Cole, PhD, Global Neurohealth Ventures

Details to be announced!

Photo: Panelists (clockwise) , Trish Costello, Portfolia; Jan Pensaert, Valiance Asset Management; Michael Cole, PhD, Global Neurohealth Ventures; and Karl Handelsman, Codon Capital and Roche Venture Fund

5:00 PM | Robertson Auditorium at UCSF Mission Bay Conference Center

5:00 PM - 8:00 PM | Fisher Atrium at UCSF Mission Bay

General Session programming will close with the immediate opening of the Evening Cocktail Reception.

Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2020 New York Forum at the New York Academy of Sciences.